TCL Archive US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma. July 28, 2000
TCL Archive UNC Oncologist Edison Liu To Direct NCI Intramural Clinical Research Programs June 28, 1996